IDEAYA Biosciences Enters Into Licensing Agreement With Jiangsu Hengrui for Cancer Drug Candidate SHR-4849

In This Article:

IDEAYA Biosciences (IDYA) said Sunday it has entered into an exclusive licensing agreement with Jian

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.